Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Refining eligibility criteria for amyotrophic lateral sclerosis clinical trials.

van Eijk RPA, Westeneng HJ, Nikolakopoulos S, Verhagen IE, van Es MA, Eijkemans MJC, van den Berg LH.

Neurology. 2019 Jan 9. pii: 10.1212/WNL.0000000000006855. doi: 10.1212/WNL.0000000000006855. [Epub ahead of print]

2.

Nerve ultrasound: A reproducible diagnostic tool in peripheral neuropathy.

Telleman JA, Herraets IJT, Goedee HS, Verhamme C, Nikolakopoulos S, van Asseldonk JH, van der Pol WL, van den Berg LH, Visser LH.

Neurology. 2018 Dec 28. pii: 10.1212/WNL.0000000000006856. doi: 10.1212/WNL.0000000000006856. [Epub ahead of print]

PMID:
30593519
3.

Applicability and added value of novel methods to improve drug development in rare diseases.

Mitroiu M, Rengerink KO, Pontes C, Sancho A, Vives R, Pesiou S, Fontanet JM, Torres F, Nikolakopoulos S, Pateras K, Rosenkranz G, Posch M, Urach S, Ristl R, Koch A, Loukia S, van der Lee JH, Roes KCB.

Orphanet J Rare Dis. 2018 Nov 12;13(1):200. doi: 10.1186/s13023-018-0925-0.

4.

Rare disease registries: potential applications towards impact on development of new drug treatments.

Jansen-van der Weide MC, Gaasterland CMW, Roes KCB, Pontes C, Vives R, Sancho A, Nikolakopoulos S, Vermeulen E, van der Lee JH.

Orphanet J Rare Dis. 2018 Sep 5;13(1):154. doi: 10.1186/s13023-018-0836-0.

5.

Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-Net.

de Kraker MEA, Sommer H, de Velde F, Gravestock I, Weiss E, McAleenan A, Nikolakopoulos S, Amit O, Ashton T, Beyersmann J, Held L, Lovering AM, MacGowan AP, Mouton JW, Timsit JF, Wilson D, Wolkewitz M, Bettiol E, Dane A, Harbarth S; COMBACTE-NET Consortium.

Clin Infect Dis. 2018 Nov 28;67(12):1922-1931. doi: 10.1093/cid/ciy516.

6.

Enalos+ KNIME Nodes: New Cheminformatics Tools for Drug Discovery.

Varsou DD, Nikolakopoulos S, Tsoumanis A, Melagraki G, Afantitis A.

Methods Mol Biol. 2018;1824:113-138. doi: 10.1007/978-1-4939-8630-9_7.

PMID:
30039404
7.

Enalos Suite: New Cheminformatics Platform for Drug Discovery and Computational Toxicology.

Varsou DD, Nikolakopoulos S, Tsoumanis A, Melagraki G, Afantitis A.

Methods Mol Biol. 2018;1800:287-311. doi: 10.1007/978-1-4939-7899-1_14.

PMID:
29934899
8.

Bayesian sample size re-estimation using power priors.

Brakenhoff TB, Roes K, Nikolakopoulos S.

Stat Methods Med Res. 2018 Jan 1:962280218772315. doi: 10.1177/0962280218772315. [Epub ahead of print]

PMID:
29717945
9.

Interval estimation of the overall treatment effect in a meta-analysis of a few small studies with zero events.

Pateras K, Nikolakopoulos S, Mavridis D, Roes KCB.

Contemp Clin Trials Commun. 2018 Jan 9;9:98-107. doi: 10.1016/j.conctc.2017.11.012. eCollection 2018 Mar.

10.

Rapid on-site evaluation during endoscopic ultrasound-guided fine-needle aspiration of lymph nodes does not increase diagnostic yield: A randomized, multicenter trial.

Kappelle WFW, Van Leerdam ME, Schwartz MP, Bülbül M, Buikhuisen WA, Brink MA, Sie-Go DMDS, Pullens HJM, Nikolakopoulos S, Van Diest PJ, Leenders M, Moons LMG, Bogte A, Siersema PD, Vleggaar FP.

Am J Gastroenterol. 2018 May;113(5):677-685. doi: 10.1038/s41395-018-0025-8. Epub 2018 Apr 23.

PMID:
29681624
11.

Comparing methods to combine functional loss and mortality in clinical trials for amyotrophic lateral sclerosis.

van Eijk RP, Eijkemans MJ, Rizopoulos D, van den Berg LH, Nikolakopoulos S.

Clin Epidemiol. 2018 Mar 19;10:333-341. doi: 10.2147/CLEP.S153196. eCollection 2018.

12.

Increasing the efficiency of clinical trials in neurodegenerative disorders using group sequential trial designs.

van Eijk RPA, Nikolakopoulos S, Ferguson TA, Liu D, Eijkemans MJC, van den Berg LH.

J Clin Epidemiol. 2018 Jun;98:80-88. doi: 10.1016/j.jclinepi.2018.02.013. Epub 2018 Feb 24. Review.

PMID:
29486281
13.

Prevention of severe infectious complications after colorectal surgery using preoperative orally administered antibiotic prophylaxis (PreCaution): study protocol for a randomized controlled trial.

Mulder T, Kluytmans-van den Bergh MFQ, de Smet AMGA, van 't Veer NE, Roos D, Nikolakopoulos S, Bonten MJM, Kluytmans JAJW; PreCaution Study Group.

Trials. 2018 Jan 19;19(1):51. doi: 10.1186/s13063-018-2439-4.

14.

Data-generating models of dichotomous outcomes: Heterogeneity in simulation studies for a random-effects meta-analysis.

Pateras K, Nikolakopoulos S, Roes K.

Stat Med. 2018 Mar 30;37(7):1115-1124. doi: 10.1002/sim.7569. Epub 2017 Dec 11.

PMID:
29230852
15.

Dynamic borrowing through empirical power priors that control type I error.

Nikolakopoulos S, van der Tweel I, Roes KCB.

Biometrics. 2018 Sep;74(3):874-880. doi: 10.1111/biom.12835. Epub 2017 Dec 11.

PMID:
29228504
16.

Treatment of electrical status epilepticus in sleep: Clinical and EEG characteristics and response to 147 treatments in 47 patients.

van den Munckhof B, Alderweireld C, Davelaar S, van Teeseling HC, Nikolakopoulos S, Braun KPJ, Jansen FE.

Eur J Paediatr Neurol. 2018 Jan;22(1):64-71. doi: 10.1016/j.ejpn.2017.08.006. Epub 2017 Oct 26.

PMID:
29128194
17.

Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials.

van Eijk RPA, Eijkemans MJC, Ferguson TA, Nikolakopoulos S, Veldink JH, van den Berg LH.

J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):156-161. doi: 10.1136/jnnp-2017-317077. Epub 2017 Oct 30.

18.

Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study.

Prince JF, van den Bosch MAAJ, Nijsen JFW, Smits MLJ, van den Hoven AF, Nikolakopoulos S, Wessels FJ, Bruijnen RCG, Braat MNGJA, Zonnenberg BA, Lam MGEH.

J Nucl Med. 2018 Apr;59(4):582-588. doi: 10.2967/jnumed.117.197194. Epub 2017 Sep 15.

PMID:
28916623
19.

A comparative study of brachial plexus sonography and magnetic resonance imaging in chronic inflammatory demyelinating neuropathy and multifocal motor neuropathy.

Goedee HS, Jongbloed BA, van Asseldonk JH, Hendrikse J, Vrancken AFJE, Franssen H, Nikolakopoulos S, Visser LH, van der Pol WL, van den Berg LH.

Eur J Neurol. 2017 Oct;24(10):1307-1313. doi: 10.1111/ene.13380. Epub 2017 Aug 1.

PMID:
28762574
20.

Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.

Timsit JF, de Kraker MEA, Sommer H, Weiss E, Bettiol E, Wolkewitz M, Nikolakopoulos S, Wilson D, Harbarth S; COMBACTE-NET consortium.

Intensive Care Med. 2017 Jul;43(7):1002-1012. doi: 10.1007/s00134-017-4802-4. Epub 2017 May 2.

21.

Diagnostic value of sonography in treatment-naive chronic inflammatory neuropathies.

Goedee HS, van der Pol WL, van Asseldonk JH, Franssen H, Notermans NC, Vrancken AJ, van Es MA, Nikolakopoulos S, Visser LH, van den Berg LH.

Neurology. 2017 Jan 10;88(2):143-151. doi: 10.1212/WNL.0000000000003483. Epub 2016 Dec 7.

PMID:
27927940
22.

Sequential designs with small samples: Evaluation and recommendations for normal responses.

Nikolakopoulos S, Roes KC, van der Tweel I.

Stat Methods Med Res. 2018 Apr;27(4):1115-1127. doi: 10.1177/0962280216653778. Epub 2016 Jun 24.

PMID:
27342574
23.

High correlation of VAS pain scores after 2 and 6 weeks of treatment with VAS pain scores at 12 weeks in randomised controlled trials in rheumatoid arthritis and osteoarthritis: meta-analysis and implications.

Karabis A, Nikolakopoulos S, Pandhi S, Papadimitropoulou K, Nixon R, Chaves RL, Moore RA.

Arthritis Res Ther. 2016 Mar 31;18:73. doi: 10.1186/s13075-016-0972-7.

24.

From Phase Ii Studies to Hta Submissions: Optimal Use of Evidence for Informed Decisions.

Karabis A, Papadimitropoulou K, Nikolakopoulos S.

Value Health. 2015 Nov;18(7):A729. doi: 10.1016/j.jval.2015.09.2779. Epub 2015 Oct 20. No abstract available.

25.

Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review.

Nikolakopoulos S, Roes KC, van der Lee JH, van der Tweel I.

Trials. 2014 Jul 8;15:274. doi: 10.1186/1745-6215-15-274. Review.

26.

An analytical approach to assess the predictive value of biomarkers in Phase II decision making.

Nikolakopoulos S, van der Wal WM, Roes KC.

J Biopharm Stat. 2013;23(5):1106-23. doi: 10.1080/10543406.2013.814377.

PMID:
23957519

Supplemental Content

Loading ...
Support Center